Amylin, rat CAS NO.124447-81-0

Amylin, rat CAS NO.124447-81-0

Amylin, rat CAS NO.124447-81-0

Amylin, rat CAS NO.124447-81-0

Amylin, rat CAS NO.124447-81-0

Amylin, rat (CAS NO. 124447-81-0) is a synthetic 37-amino acid peptide representing the rat isoform of Islet Amyloid Polypeptide (IAPP). This research-grade hormone is co-secreted with insulin from pancreatic β-cells. The rat amylin sequence differs significantly from the human sequence at key positions, making it non-amyloidogenic. It is an essential tool for studying the physiological roles of amylin in glucose homeostasis, satiety, and gastric emptying in rodent models, without the confounding pathology of amyloid aggregation seen with human or feline amylin.



TECHNICAL SPECIFICATIONS


Item
Specification
Product Name
 Amylin, rat
CAS NO.
124447-81-0
Appearance
White to off-white lyophilized powder
Molecular Formula
C₁₆₄H₂₅₉N₅₁O₅₄S₂
Molecular Weight
 3891.34g/mol
Purity (RP-HPLC)
≥ 95.0%
Solubility

Soluble in water (5 mg/mL) or 5% acetic acid; also soluble in DMSO

Endotoxin< 1.0 EU/mg
Biological Activity
A 37-amino acid pancreatic peptide; inhibits glucagon secretion, delays gastric emptying, and acts as a satiety agent. In rat models, it modulates glucose homeostasis and is associated with islet amyloid formation in diabetes.
Storage Conditions
-20°C for long-term storage ; avoid repeated freeze-thaw cycles. Store as aliquots in sealed vials.
Stock Location
Stock in USA
MOQ
1g


1.MECHANISM OF ACTION

Rat amylin exerts its physiological effects by binding to and activating specific amylin receptors, which are complexes of the Calcitonin Receptor (CTR) and Receptor Activity-Modifying Proteins (RAMPs). Its primary mechanisms in rodent models are:
  1. Inhibition of Glucagon Secretion: Acts on the pancreas to suppress postprandial glucagon release from α-cells, reducing hepatic glucose output.
  2. Delay of Gastric Emptying: Signals via receptors in the hindbrain (area postrema) to slow the rate at which food empties from the stomach into the small intestine, moderating the post-meal rise in blood glucose.
  3. Induction of Satiety: Acts centrally in the brain to promote feelings of fullness, leading to reduced food intake. This anorexigenic effect is a key area of study in obesity research.
  4. Critical Distinction – Non-Amyloidogenic: Unlike human or feline amylin, rat amylin contains proline substitutions that prevent β-sheet formation and toxic aggregation. This makes it ideal for studying amylin's native hormonal signaling without the complication of islet amyloid pathology.

 

2.PRODUCT INDICATIONS

This product is specifically indicated for preclinical research using rat models in metabolism, endocrinology, and neuroscience. Key applications include:
  • Physiology of Glucose Homeostasis: Studying the normal, protective role of amylin in postprandial glucose regulation in healthy and diabetic rodent models.
  • Obesity & Feeding Behavior Research: Investigating the anorexigenic (satiety) effects of amylin and its potential as a target for weight loss therapies.
  • Pharmacology of Amylin & Analogs: Serving as the species-specific reference agonist for testing the effects of endogenous amylin or novel amylin mimetics (like pramlintide) in rat-based experiments.
  • Comparative Biology: Contrasting the effects of non-amyloidogenic (rat) vs. amyloidogenic (human) amylin sequences in cellular and animal models to understand the structural basis of toxicity.
  • Gastrointestinal Motility Studies: Research on hormonal control of gastric emptying.

3.CLINICAL EFFICACY OF PRODUCT

Rat amylin itself is not a human therapeutic. However, research using rat amylin has been fundamentally critical for establishing the physiological actions of the amylin hormone system, which directly enabled clinical drug development.
  • Foundational Science: Studies in rats (and mice) using rat amylin or its analogs were instrumental in proving that amylin:
    • Reduces food intake and promotes weight loss.
    • Lowers blood glucose via glucagon suppression and gastric emptying delay.
  • Enabling Drug Development: This robust physiological data from rodent models validated the amylin pathway as a therapeutic target for diabetes and obesity. It provided the essential proof-of-concept that led to the development of pramlintide, the stable, non-aggregating human amylin analog approved for diabetes treatment.
  • Safety Profile Evidence: The non-toxic nature of rat amylin in rodent islets helped differentiate the hormone's beneficial signaling effects from the detrimental amyloid effects of human IAPP.


4.DELIVERY & SHIPPING

We specialize in global logistics for various cosmetic peptides. Your order will be handled with the utmost care, ensuring safe, reliable, and intact delivery.
Professional and Secure Packaging
Each bottle of peptide is protected with a special packaging solution to ensure stability and integrity during transportation.
We can also customize packaging according to customer needs.
Shipping Methods 
Main Method: International Air Freight

We primarily use DHL, FedEx, UPS, and TNT because of their global reliability, speed, and advanced tracking systems. Air freight ensures the fastest transit time and minimizes the impact of environmental factors on the product.

Premium API Oxandrolone Ucinky Manufacturing
May 25, 26
Premium API Oxandrolone Ucinky Manufacturing
Premium API Oxandrolone Ucinky Manufacturing Leading global supplier of high-purity chemical raw materials for pharmaceutical grade Oxandrolone Ucinky, combining precision engineering with industrial scale. 5000 kg Annual Output 120 Countries Served 5 Days Sample Lead Time 99.7 On-Time Delivery Industrial Precision Pure Chemical Synthesis Engineering the future of pharmaceutical intermediates with unmatched stability. Our facility stands as a global leader in the oxandrolone ucinky sector, utilizing CRYOGENIC CRYSTALLIZATION and advanced chromatography to ensure an assay purity exceeding 99.8. We integrate a fully automated closed-loop system that eliminates human error and contamination.
Clinical Benefits and Applications of Oxandrolone Therapy
May 22, 26
Clinical Benefits and Applications of Oxandrolone Therapy
Oxandrolone therapy represents a sophisticated intersection of endocrine science and regenerative medicine, primarily utilized to address muscle wasting and metabolic dysfunction. In the global pharmaceutical landscape, this specific approach to androgen therapy is valued for its unique ability to promote protein synthesis while exhibiting a lower androgenic profile compared to traditional steroids, making it a critical tool for patients recovering from severe trauma or chronic illness. From a clinical perspective, understanding the nuances of oxandrolone therapy is essential for optimizing patient outcomes in weight gain and tissue repair.
Clinical Benefits and Production of Oxandrolone Steroid
May 20, 26
Clinical Benefits and Production of Oxandrolone Steroid
The global pharmaceutical landscape has seen a significant rise in the demand for highly specialized anabolic agents, among which the oxandrolone steroid stands out due to its unique chemical profile and therapeutic versatility. As a modified version of dihydrotestosterone, this compound provides a potent means of addressing muscle wasting and metabolic deficits, making it a critical asset in both clinical rehabilitation and advanced physiological research. Understanding the nuances of this synthetic compound is essential for healthcare providers and researchers alike, as it balances efficacy with a relatively lower androgenic profile compared to other steroids.

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.